Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Clinical Post-Transplant Lymphoproliferative Disorders Publisher Pubmed



Aghsaeifard Z1 ; Alizadeh R2
Authors

Source: Cardiovascular and Hematological Disorders - Drug Targets Published:2022


Abstract

Post-transplant lymphoproliferative disorders (PTLDs) are characterized by hyperprolife-ration of B cells due to solid organ or allogeneic hematopoietic stem cell transplant. Based on histological findings, it is divided into 4 categories. Most PTLD patients are Epstein–Barr virus (EBV) positive. Additionally, aggressive immunosuppressive therapies can also lead to PTLD. Reducing immunosuppressive regimes, antivirals, monoclonal antibodies, chemotherapy, and radiotherapy are available therapeutic options, depending on the nature and phase of the disease. This review briefly highlights pathogenesis, risk factors, prevention, and therapeutic strategies regarding PTLDs. © 2022 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Impact of Antiviral Prophylaxis on Ebv Viremia and Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis, Virology Journal (2025)
2. Extended Clinical and Immunological Phenotype and Transplant Outcome in Cd27 and Cd70 Deficiency, Blood (2020)
3. Association Between Neutrophil Gelatinase-Associated Lipocalin (Ngal) and Iron Profile in Chronic Renal Disease, Archives of Physiology and Biochemistry (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Ziba Aghsaeifard (4)
Other Related Docs
4. Postoperative Complications Associated With Coronary Artery Bypass Graft Surgery and Their Therapeutic Interventions, Future Cardiology (2020)
5. B Cell Modulation Strategies in the Improvement of Transplantation Outcomes, Molecular Immunology (2020)
6. Post-Transplant Cyclophosphamide Versus Anti-Thymocyte Globulin As Graft- Versus-Host Disease Prophylaxis in Haploidentical Transplant, Haematologica (2017)
7. Therapeutic Approaches for Htlv-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review, Medical Oncology (2023)
8. A Cross-Sectional Study on the Postoperative Analgesic-Associated Side Effects and Clinical Parameters Following Partial Mastectomy, International Journal of Surgery Open (2020)
9. Primary Cutaneous Cd4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoma Following Heart Transplantation, International Journal of Organ Transplantation Medicine (2017)
10. Intestinal Transplantation: Significance of Immune Responses, Arab Journal of Gastroenterology (2024)
11. Asymptomatic Epstein-Barr Virus Shedding in the Urine of Kidney Transplant Recipients: Case Reports and Review of the Literature, Infectious Disease Reports (2016)
12. Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma, Expert Review of Anticancer Therapy (2021)
13. Effects of Aminophylline on the Levels of Neutrophil Gelatinase-Associated Lipocalin (Ngal) in Asphyxiated Term Neonates, Archives of Physiology and Biochemistry (2022)
14. Combined Immunodeficiency and Epstein-Barr Virus- Induced B Cell Malignancy in Humans With Inherited Cd70 Deficiency, Journal of Experimental Medicine (2017)
15. Pregnancy and Sex Hormone Changes After Kidney Transplant; [Embarazo Y Cambios Hormonales Sexuales Despues De Un Trasplante De Rinon], Clinica e Investigacion en Ginecologia y Obstetricia (2023)
16. Impact of Anti-Thymocyte Globulin on Results of Allogeneic Peripheral Blood Stem Cell Transplantation for Patients With Philadelphia-Positive Acute Lymphoblastic Leukaemia: An Analysis by the Acute Leukemia Working Party of the Ebmt, European Journal of Cancer (2019)
17. Spotlight on the Impact of Viral Infections on Hematopoietic Stem Cells (Hscs) With a Focus on Covid-19 Effects, Cell Communication and Signaling (2023)
18. Optimizing Peripheral Blood Stem Cells Transplantation Outcome Through Amend Relapse and Graft Failure: A Review of Current Literature, Experimental Hematology and Oncology (2017)
19. Primary Immunodeficiencies Associated With Ebv-Induced Lymphoproliferative Disorders, Critical Reviews in Oncology/Hematology (2016)
20. Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes, Cardiovascular and Hematological Disorders - Drug Targets (2020)